Skip to main content

Table 1 Rare disruptive variants (MAF ≤ 0.001, CADD phred≥20) in the 26 PD candidate genes identified in the discovery families

From: Identification of sixteen novel candidate genes for late onset Parkinson’s disease

CHR

Genomic position (hg19)

dbSNP

Gene

RefSEq

Nucleotide Change

AA Change

Exonic Function

Cl

MAF Max in public data sets

CADD phred

Family

16

723,544

rs143816083

RHOT2

NM_138769

c.G1795T

p.G599W

NSV

N

0.0001

25

1

3

184,039,223

rs746291399

EIF4G1

NM_198241

c.C851G

p.S284C

NSV

N

0.00004

25

2

1

8,022,928

rs142405016

PARK7

NM_007262

c.G83A

p.R28Q

NSV

 

0.0002

35

5

7

6,062,997

rs749728733

AIMP2

NM_006303

c.T638C

p.I213T

NSV

N

0.00002

27

7

2

86,408,450

rs201861204

IMMT

NM_001100169

c.C91T

p.R31C

NSV

N

0.0002

26

7

1

20,971,042

rs74315358

PINK1

NM_032409

c.G836A

p.R279H

NSV

P

0.00004

26

7

16

89,717,990

 

CHMP1A

NM_002768

c.C92T

p.A31V

NSV

N

NA

23

9

2

74,757,823

 

HTRA2

NM_013247

c.A586G

p.N196D

NSV

N

NA

23

9

3

132,222,165

 

DNAJC13

NM_015268

c.C4824G

p.S1608R

NSV

N

NA

20

10

17

42,398,033

 

SLC25A39

NM_001143780

c.C758A

p.T253N

NSV

N

NA

21

10

2

54,895,594

rs200093475

SPTBN1

NM_003128

c.C6983A

p.T2328N

NSV

N

0.00004

27

12

22

39,078,021

rs200476832

TOMM22

NM_020243

c.C38T

p.P13L

NSV

N

0.0002

25

12

19

14,589,354

 

GIPC1

NM_202470

c.875dupA

p.K292fs

Fs_ins

N

NA

NA

13

6

162,394,354

rs114974496

PARK2

NM_004562

c.C714G

p.C238W

NSV

P

0.00004

25

13

5

121,787,252

rs751412863

SNCAIP

NM_005460

c.A2710G

p.K904E

NSV

N

0.00004

24

14

12

40,704,237

rs34995376

LRRK2

NM_198578

c.G4322A

p.R1441H

NSV

P

0.00001

27

14

7

99,654,828

 

ZSCAN21

NM_145914

c.C199T

p.R67W

NSV

N

NA

24

16

9

34,290,328

rs372797268

KIF24

NM_194313

c.T971C

p.I324T

NSV

N

0.0001

26

17

16

10,911,991

 

TVP23A

NM_001079512

c.G58T

p.E20X

stopgain

N

NA

38

18

1

65,858,474

 

DNAJC6

NM_001256864

c.C1829T

p.P610L

NSV

N

NA

23

19

15

75,652,021

 

MAN2C1

NM_001256494

c.1882_1887del

p.628_629del

NFs_del

N

NA

NA

19

15

75,652,016

 

MAN2C1

NM_001256494

c.1890_1892del

p.630_631del

NFs_del

N

NA

NA

19

22

32,870,999

 

FBXO7

NM_012179

c.C10T

p.R4W

NSV

N

NA

33

20

16

4,557,822

rs772245870

HMOX2

NM_001286271

c.C226T

p.R76W

NSV

N

0.00001

34

20

1

200,957,957

rs751952433

KIF21B

NM_001252100

c.G3235A

p.A1079T

NSV

N

0.00002

29

21

11

122,931,465

 

HSPA8

NM_006597

c.G247A

p.V83I

NSV

N

NA

21

24

4

947,062

 

TMEM175

NM_032326

c.C547T

p.R183X

stopgain

N

NA

34

25

1

200,974,537

 

KIF21B

NM_001252100

c.C631T

p.R211C

NSV

N

NA

34

26

  1. CHR Chromosome, hg19 human genome build to which these variants are annotated, dbSNP reference number in SNP database, ref. seq reference number of the gene transcript, AA Change Amino acid change, CI Clinical interpretation, P Pathogenic, UP Uncertain pathogenicity, N Novel, PD Parkinson’s disease, IPDGC International Parkinson’s Disease Genetics Consortium, CADD phred Combined Annotation Dependent Depletion, Fs_ins Frame shift insertion, NFs_del Non Frame shift deletion, NSV Non-synonymous variant, MAF Minor Allele Frequency, NA Not Annotated, MAF max in public datasets: highest allelic frequency annotated in public databases including 1000 Genomes Project (AFR. AMR. EAS. EUR. SAS), ExAC browser (NFE. AFR. SAS. EAS and AMR), ESP6500si-v2 (European American and African American population)